Lymphoma is an umbrella term which refers to two different types of cancers that originate in the lymphatic system: Hodgkin’s lymphoma (aka Hodgkin’s disease) and non-Hodgkin’s lymphoma. Lymphoma is also considered to be one of the “most curable” forms of cancer.
Hodgkin’s disease is generally more treatable than non-Hodgkin’s lymphoma (NHL). NHL five and 10-year relative survival rates are 69 percent and 59 percent, respectively. For Hodgkin’s disease, these survival rates rise to 85 percent for five-year and 80 percent for 10-year.
The chances of recovery are higher if lymphoma is discovered in the early stages. Lymphoma staging can be broken down as follows:
- Stage I – At Stage I, the cancer has been found in one lymph node region. At Stage IE, the cancer has been detected in one organ outside of the lymphatic system, but not in any lymph node regions.
- Stage II – At Stage II, the cancer is in 2 or more areas on the same side of the diaphragm. In Stage IIE, the cancer affects one organ and surrounding lymph nodes on the same side of the diaphragm.
- Stage III – Cancer is found in lymph nodes on both sides of the diaphragm.
- Stage IV – Cancer has spread throughout the body, such as to the liver, lungs, or bone marrow.
- Progressive – When cancer grows or spreads while lymphoma is being treated
- Recurrent – When lymphoma returns after being treated. This can happen shortly after treatment or years later.
Kevin Marciano, Esquire, is the Managing Partner of Marciano & MacAvoy, P.C and a cancer misdiagnosis lawyer in Philadelphia. Kevin focuses his practice on representing catastrophic injury victims, including claims for medical malpractice, pharmaceutical liability, motor vehicle accidents, and other personal injury and mass tort matters.